Alan Hoi Lun Yau1, Cherry Galorport2,3, Carla S Coffin4,3, Hin Hin Ko2. 1. Author Affiliation Department of Medicine, Division of Gastroenterology, University of British Columbia, Vancouver, Canada. 2. Department of Medicine, Division of Gastroenterology, St. Paul's Hospital, University of British Columbia, Vancouver, Canada. 3. on behalf of the Canadian Hepatitis B Network. 4. Department of Medicine, Division of Gastroenterology and Hepatology, Alberta Health Services, University of Calgary, Calgary, Alberta, Canada.
Abstract
BACKGROUND: xpert guidelines recommend hepatocellular carcinoma (HCC) surveillance among patients with high-risk chronic hepatitis B (CHB); however, physician screening practices are often variable. METHODS: An online survey of HCC screening practice was distributed to members of the Canadian Association for the Study of the Liver. Data were analyzed using appropriate statistical tests with p < .05 significance. RESULTS: Of 71 respondents, 86% (n = 61) were gastroenterologists or hepatologists, and 72% (n = 51) reported having been in clinical practice for more than 5 years. A significant number of survey respondents performed HCC screening without consideration of concomitant non-alcoholic fatty liver disease (50.7%); non-Asian, non-African ethnicity (46.4%); and family history of HCC (28.6%). Most (67.6%) performed screening with ultrasound (US) at the time of specialty clinic visits, 28.2% had an automatic recall system, and only 2.8% referred back to primary care physicians to organize screening. More than half (54.9%) included alpha-fetoprotein in screening. Obstacles to screening included lack of an automatic recall system (42.9%), patient non-compliance (30.0%), and limited US/MRI access (17.1%). CONCLUSIONS: HCC screening practices with hepatitis B patients vary widely among Canadian specialists, especially in unique populations with limited data to inform screening recommendations. Implementation of an automatic recall system could potentially increase HCC surveillance.
BACKGROUND: xpert guidelines recommend hepatocellular carcinoma (HCC) surveillance among patients with high-risk chronic hepatitis B (CHB); however, physician screening practices are often variable. METHODS: An online survey of HCC screening practice was distributed to members of the Canadian Association for the Study of the Liver. Data were analyzed using appropriate statistical tests with p < .05 significance. RESULTS: Of 71 respondents, 86% (n = 61) were gastroenterologists or hepatologists, and 72% (n = 51) reported having been in clinical practice for more than 5 years. A significant number of survey respondents performed HCC screening without consideration of concomitant non-alcoholic fatty liver disease (50.7%); non-Asian, non-African ethnicity (46.4%); and family history of HCC (28.6%). Most (67.6%) performed screening with ultrasound (US) at the time of specialty clinic visits, 28.2% had an automatic recall system, and only 2.8% referred back to primary care physicians to organize screening. More than half (54.9%) included alpha-fetoprotein in screening. Obstacles to screening included lack of an automatic recall system (42.9%), patient non-compliance (30.0%), and limited US/MRI access (17.1%). CONCLUSIONS: HCC screening practices with hepatitis B patients vary widely among Canadian specialists, especially in unique populations with limited data to inform screening recommendations. Implementation of an automatic recall system could potentially increase HCC surveillance.
Authors: Karen E A Burns; Mark Duffett; Michelle E Kho; Maureen O Meade; Neill K J Adhikari; Tasnim Sinuff; Deborah J Cook Journal: CMAJ Date: 2008-07-29 Impact factor: 8.262
Authors: Amit G Singal; Adam Yopp; Celette S Skinner; Milton Packer; William M Lee; Jasmin A Tiro Journal: J Gen Intern Med Date: 2012-01-04 Impact factor: 5.128
Authors: Daniel A Leffler; Naama Neeman; James M Rabb; Jacob Y Shin; Bruce E Landon; Kumar Pallav; Z Myron Falchuk; Mark D Aronson Journal: Gastroenterology Date: 2011-01-13 Impact factor: 22.682